Cargando…

Cyclic Oligosaccharides as Active Drugs, an Updated Review

There have been many reviews of the cyclic oligosaccharide cyclodextrin (CD) and CD-based materials used for drug delivery, but the capacity of CDs to complex different agents and their own intrinsic properties suggest they might also be considered for use as active drugs, not only as carriers. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Matencio, Adrián, Caldera, Fabrizio, Cecone, Claudio, López-Nicolás, José Manuel, Trotta, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601923/
https://www.ncbi.nlm.nih.gov/pubmed/33003610
http://dx.doi.org/10.3390/ph13100281
_version_ 1783603548313878528
author Matencio, Adrián
Caldera, Fabrizio
Cecone, Claudio
López-Nicolás, José Manuel
Trotta, Francesco
author_facet Matencio, Adrián
Caldera, Fabrizio
Cecone, Claudio
López-Nicolás, José Manuel
Trotta, Francesco
author_sort Matencio, Adrián
collection PubMed
description There have been many reviews of the cyclic oligosaccharide cyclodextrin (CD) and CD-based materials used for drug delivery, but the capacity of CDs to complex different agents and their own intrinsic properties suggest they might also be considered for use as active drugs, not only as carriers. The aim of this review is to summarize the direct use of CDs as drugs, without using its complexing potential with other substances. The direct application of another oligosaccharide called cyclic nigerosyl-1,6-nigerose (CNN) is also described. The review is divided into lipid-related diseases, aggregation diseases, antiviral and antiparasitic activities, anti-anesthetic agent, function in diet, removal of organic toxins, CDs and collagen, cell differentiation, and finally, their use in contact lenses in which no drug other than CDs are involved. In the case of CNN, its application as a dietary supplement and immunological modulator is explained. Finally, a critical structure–activity explanation is provided.
format Online
Article
Text
id pubmed-7601923
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76019232020-11-01 Cyclic Oligosaccharides as Active Drugs, an Updated Review Matencio, Adrián Caldera, Fabrizio Cecone, Claudio López-Nicolás, José Manuel Trotta, Francesco Pharmaceuticals (Basel) Review There have been many reviews of the cyclic oligosaccharide cyclodextrin (CD) and CD-based materials used for drug delivery, but the capacity of CDs to complex different agents and their own intrinsic properties suggest they might also be considered for use as active drugs, not only as carriers. The aim of this review is to summarize the direct use of CDs as drugs, without using its complexing potential with other substances. The direct application of another oligosaccharide called cyclic nigerosyl-1,6-nigerose (CNN) is also described. The review is divided into lipid-related diseases, aggregation diseases, antiviral and antiparasitic activities, anti-anesthetic agent, function in diet, removal of organic toxins, CDs and collagen, cell differentiation, and finally, their use in contact lenses in which no drug other than CDs are involved. In the case of CNN, its application as a dietary supplement and immunological modulator is explained. Finally, a critical structure–activity explanation is provided. MDPI 2020-09-29 /pmc/articles/PMC7601923/ /pubmed/33003610 http://dx.doi.org/10.3390/ph13100281 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Matencio, Adrián
Caldera, Fabrizio
Cecone, Claudio
López-Nicolás, José Manuel
Trotta, Francesco
Cyclic Oligosaccharides as Active Drugs, an Updated Review
title Cyclic Oligosaccharides as Active Drugs, an Updated Review
title_full Cyclic Oligosaccharides as Active Drugs, an Updated Review
title_fullStr Cyclic Oligosaccharides as Active Drugs, an Updated Review
title_full_unstemmed Cyclic Oligosaccharides as Active Drugs, an Updated Review
title_short Cyclic Oligosaccharides as Active Drugs, an Updated Review
title_sort cyclic oligosaccharides as active drugs, an updated review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601923/
https://www.ncbi.nlm.nih.gov/pubmed/33003610
http://dx.doi.org/10.3390/ph13100281
work_keys_str_mv AT matencioadrian cyclicoligosaccharidesasactivedrugsanupdatedreview
AT calderafabrizio cyclicoligosaccharidesasactivedrugsanupdatedreview
AT ceconeclaudio cyclicoligosaccharidesasactivedrugsanupdatedreview
AT lopeznicolasjosemanuel cyclicoligosaccharidesasactivedrugsanupdatedreview
AT trottafrancesco cyclicoligosaccharidesasactivedrugsanupdatedreview